Overweight and obesity affect over 20% of children worldwide. Emerging evidence shows that 37 nonnutritive sweeteners (NNS) could adversely influence weight gain and metabolic health, particularly 38 during critical periods of development. Thus, we aimed to investigate the impact of prenatal NNS 39 exposure on postnatal growth and adiposity. Among 2298 families participating in the CHILD cohort 40 study, children born to mothers who regularly consumed NNS during pregnancy had elevated body mass 41 index and adiposity at 3 years of age. In a complementary study designed to eliminate confounding by 42 human lifestyle factors and investigate causal mechanisms, we exposed pregnant mice and cultured 43 adipocytes to NNS (aspartame or sucralose) at doses relevant to human consumption. In mice, maternal 44 NNS exposure caused elevated body weight, adiposity and insulin resistance in offspring, especially in 45 males. Further, in 3T3-L1 pre-adipocyte cells, sucralose exposure during early stages of differentiation 46 caused increased lipid accumulation and expression of adipocyte differentiation genes (e.g. C/EBP-α, 47 FABP4, FAS). The same genes were upregulated in the adipose tissue of male mouse offspring born to 48 sucralose-fed dams. Together, these clinical and experimental findings provide evidence suggesting that 49 maternal NNS consumption induces obesity risk in the offspring through effects on adiposity and 50 adipocyte differentiation. 51
NNS intake (a combination of sucralose and acesulfame-K at 2-fold ADI) altered the microbiome and 85 metabolism of young offspring and reduced their total body weight (24), although adiposity was not 86 assessed and the offspring were not followed beyond the weaning period. Von Poster Toigo et al. found 87 that rats exposed to an even higher dose of NNS (343 mg/kg/day aspartame; 8.6-fold ADI) during 88 gestation gain more weight and have altered lipid profiles during adulthood (25) , yet other studies have 89 reported no difference in weight gain following prenatal NNS exposure (26) . Similarly, conflicting 90 evidence from in vitro studies suggests that NNS can either stimulate (27) or downregulate (28, 29) 91 adipocyte differentiation. 92 93 Overall there is a paucity of evidence from human and experimental studies on the potential impact of 94 prenatal NNS exposure on the development of obesity and metabolic health. Here, we extend our 95 previous findings on maternal NNS beverage consumption and infant body composition in the CHILD 96 cohort (14) by re-assessing this relationship at 3 years of age. Further, we use experimental model 97 systems to examine the underlying mechanisms in mice, using physiologically relevant doses of both 98 aspartame and sucralose. Finally, we characterized these mechanisms using an in vitro model of 99 adipocyte differentiation and show for the first time that sucralose exerts effects on adiposity and 100 adipocyte differentiation. The combination of clinical and experimental findings provides new evidence 101 that maternal NNS consumption conditions obesity risk in the offspring. 102 103
Results 104
Maternal NNS intake during pregnancy is associated with higher BMI and adiposity in children 105
Building on our previous findings at 1 year of age in the CHILD pregnancy cohort (14), we re-examined 106 the association of maternal NNS consumption and child body composition at 3 years of age among 2298 107 mother-child dyads. During pregnancy, 29.9% of mothers reported consuming any NNS beverages and 108 5.2% consumed them daily (Table S1 ). Consistent with our previous results, children born to mothers 109 reporting daily NNS beverage consumption had significantly higher BMIs at 3 years of age than children 110 born to mothers who did not consume NNS beverages (mean z-score 0.88 ± 0.97 vs. 0.53 ± 0.96; crude 111 β = 0.37, 95% CI 0.19 -0.55), although this association was partially attenuated after adjusting for 112 potential confounders including maternal BMI, diabetes, smoking and overall diet quality, child diet 113 quality and screen time (aβ = 0.17, 95% CI -0.05 -0.39) ( Fig. 1 and Table S2 ). Similar results were 114 observed for girls and boys, and for the adiposity outcome of subscapular skin folds ( Fig. 1 and Table  115 S3). Together, these results suggest that maternal NNS consumption during pregnancy may promote 116 excessive weight gain or adiposity in offspring, although confounding by lifestyle factors appears to 117 partially explain this relationship. To eliminate the possibility of confounding, determine causality and 118 investigate biological mechanisms, we undertook mechanistic studies exposing pregnant mice and 119 cultured adipoctyes to NNS at doses relevant to human consumption. 120 121 Sucrose and NNS variably impact weight gain and energy intake in pregnant mice 122 At e18.5, pregnant mice receiving sucrose in their drinking water weighted more than the control dams, 123 although this difference did not reach statistical significance ( Table 1) . Dams receiving sucrose 124 consumed more sweetened water and more food, thus their average daily energy intake was ~1.4-fold 125 greater than controls (Table 1; p<0.01). Dams receiving aspartame or sucralose increased their food 126 intake by a lesser degree (1.1 and 1.2 fold, respectively; p<0.01), but their body weight was not affected. 127
Notably, maternal sucrose and aspartame consumption increased the number of pups in the litters (Table  128 1; p<0.01) whereas sucralose did not significantly affect the litter size. 129
130
Maternal NNS intake has sex-specific effects on adiposity in mouse offspring 131
Next, we investigated the influence of maternal NNS intake on weight gain in male and female mouse 132 offspring. Maternal sucrose, aspartame and sucralose consumption all conditioned increased body weight 133 in male offspring by 7 weeks of age compared to the male offspring of control dams ( Fig. 2A; all  134 p<0.001). The elevated body weight in these male offspring persisted until sacrifice at 11 weeks of age. 135
Conversely in female offspring, only maternal sucrose consumption (not aspartame or sucralose) induced 136 elevated body weight at 10 and 11 weeks of age ( Fig. 2B; p<0 .05). Interestingly, the elevated body weight 137 did not appear to be due to differences in energy intake because average daily food intake was similar 138 across all offspring groups (Table S4) . 139
140
To determine whether increased body weight was related to alterations in lean and/or fat mass in the 141 offspring, we performed dual energy X-ray absorptiometry (DXA). This analysis showed that maternal 142 sucrose, aspartame and sucralose all markedly increase the percent body fat (50%, 47%, and 15% 143 increases, respectively) in male offspring, compared to controls ( Fig. 2C; p<0 .0001). Maternal sucrose 144 and aspartame also increased the percent body fat in female offspring ( Fig. 2C; p<0 .05); however, 145 sucralose had no effect on percent body fat in females. Consistent with these observations, maternal 146 consumption of sucrose, aspartame and sucralose all increased the weight of perirenal white adipose 147 tissue (pWAT) and gonadal white adipose tissue (gWAT) fat pads of the male offspring, compared to 148 controls ( Fig. 2D; p<0 .05). Notably, the effect of sucralose was dose dependent, as lower levels of 149 sucralose administration to dams did not induce elevated body weight and fat pad mass in the male 150 offspring (Table S5) . H&E staining of perirenal adipose tissue ( Fig. 2E ) revealed that maternal 151 aspartame and sucralose consumption increased the mean adipocyte diameter of the male offspring by 152 22% and 30%, respectively (Fig. 2F, p<0 .05). Adipose tissue was the only major organ system that 153 increased in weight; the liver, heart, kidney and spleen of the offspring were generally similar between 154 all groups (Table S6 ). One notable exception was increased liver mass in female offspring of sucrose-155 fed dams (Table S6) . 156
157
Maternal NNS intake has sex-specific effects on insulin sensitivity in mouse offspring 158
Next, since maternal NNS consumption increased body fat accumulation in offspring, we examined 159 whether insulin sensitivity was also affected. Glucose tolerance tests of the male offspring did not show 160 any differences across groups (Fig. 3A, B) . In the female offspring, maternal sucrose consumption 161 induced significant glucose intolerance, while maternal aspartame and sucralose consumption had no 162 effect ( Fig. 3C, D) . Insulin tolerance tests revealed that the male offspring of sucrose, aspartame and 163 sucralose-fed dams were more insulin resistant than the male offspring of control dams (Fig. 3E, F) . 164 However, the insulin sensitivity of the female offspring was similar across all groups (Fig. 3G, H) . 165
166

Sucralose has pro-adipogenic effects on 3T3-L1 pre-adipocytes in vitro 167
Since maternal NNS influenced body fat accumulation in male mouse offspring, and early-life is a critical 168 stage that determines stem cell fate, we examined the effects of sucralose in cultured cells using the well-169 established male 3T3-L1 pre-adipocyte cell line. Previous research has shown that aspartame affects lipid 170 accumulation and adipocyte differentiation in 3T3-L1 cells (29). Therefore, we examined the stage(s) of 171 adipocyte differentiation affected by sucralose. To this end, the 3T3-L1 adipocytes were incubated with 172 induction medium in the presence or absence of sucralose (200nM) for the indicated periods of time, as 173 illustrated in Fig. 4A . As expected, control cells incubated with induction medium for 8 days 174 differentiated into adipocytes, exhibited by lipid accumulation as judged by oil red staining ( Fig. 4B,  175 treatment a). Cells treated with sucralose from d0-d2 (treatment b, modeling germline exposure) or d0-176 d8 (treatment e, throughout differentiation) exhibited the highest accumulation of lipid ( Fig. 4B) . Of 177 note, lipid accumulation was not significantly affected by sucralose treatment in other time windows, 178 including d2-d4 (treatment c, modeling fetal exposure) or d4-d8 (treatment d, modeling postnatal 179 exposure) Fig. 4B ). These results collectively suggest that sucralose administration enhances 180 adipogenesis at an early phase of differentiation, consistent with the effects of prenatal NNS exposure 181 on body fat accumulation observed in mice ( Fig. 2) and 3 year-old participants in the CHILD study ( Fig.  182   1) . 183 184
Sucralose stimulates pro-adipogenic regulators and enzymes in vitro and in vivo 185
Since adipocyte differentiation is a complex process that can be modulated by multiple stimuli including 186 transcription factors, we examined how sucralose affected the gene expression of regulators of the 187 adipocyte phenotype. The addition of sucralose to the culture media from d0-d8 (treatment e) induced a 188 small but significant increase in the expression of the peroxisomal proliferator activated receptor 189 (PPAR)-γ transcription factor at d8 of adipocyte differentiation (Pparg; Fig. 5A ). On the other hand, the 190 addition of sucralose earlier in the adipocyte differentiation program as well as throughout (treatments c 191 and e), induced marked increases in the expression of the adipogenesis-dependent transcription factor, 192 CCAT enhancer binding protein (C/EBP)-α by d8 of adipocyte differentiation (Cebpa; Fig. 5B ). 193
Moreover, the addition of sucralose to the media at the early stages of differentiation (treatments b and 194 c) as well as throughout (treatment e), induced 1.5 to 2-fold increases in the mRNA expression of the 195 adipocyte marker genes, adiponectin (Adipoq; Fig. 5C ) and fatty acid binding protein (Fabp4; Fig. 5D ). 196
Consistent with these findings, sucralose also increased the expression of the lipid droplet coat protein, 197 perilipin (Plin2; Fig. 5E ). Sucralose did not affect the expression of the adipogenesis inhibitory factor, 198
Pref-1 ( Fig. 5F ), suggesting that most of the effects of sucralose are driven by promoting adipogenesis 199 rather than removing factors that maintain the undifferentiated state. Overall, treatment of the cells with 200 sucralose at earlier stages of adipocyte differentiation had remarkable effects on regulators of the 201 adipocyte phenotype whereas treatment of the cells with sucralose at later stages had no effect. 202 203 Next, we examined whether sucralose also impacted the expression of genes encoding metabolic 204 enzymes involved in fat storage and mobilization during adipocyte differentiation. Indeed, sucralose 205 administration early in the adipocyte differentiation program increased the expression of fatty acid 206 synthase (Fasn; Fig. 6A ) as well as glycerol phosphate acyltransferase (Gpam; Fig. 6B ). Sucralose also 207 significantly increased the expression of hormone sensitive lipase (Lipe; Fig. 6C ) and adipose tissue 208 triglyceride lipase (Atgl; Fig. 6D ). These findings suggest that sucralose promotes fatty acid and 209 triacylglycerol synthesis as well as its mobilization in differentiating 3T3-L1 adipocytes. 210 211 Finally, we assessed whether maternal sucralose consumption also affected the expression of several of 212 these genes in the pWAT of male mouse offspring. Interestingly, in the offspring of sucralose-fed dams, 213 as well as sucrose-fed and aspartame-fed dams, a ~1.5-fold increase Cebpa and Fabp4 mRNA expression 214 in pWAT was observed compared to the offspring of control dams (Fig. 7A, B ). In addition, sucralose 215 (but not sucrose or astpartame) increased Fasn and Gpam mRNA expression ~7-fold and ~3-fold, 216
respectively, compared to the offspring of control dams (Fig. 7C, D) . 217
218
Discussion 219 220 Our study provides new evidence on the potential adverse effects of NNS, which are typically marketed 221 as 'healthier' alternatives to caloric sweeteners, especially for the purposes of weight management and 222 diabetes control. Given that maternal obesity and gestational diabetes are on the rise (30), NNS may be 223 especially appealing to pregnant women, yet very few studies have explored the long-term impact of 224 NNS exposure in utero. Here, we used a translational approach to triangulate evidence from a human 225 cohort, a mouse model, and cell culture experiments to show that prenatal NNS exposure influences 226 adipocyte differentiation, fat mass accumulation, and adiposity in offspring. 227
228
In the prospective CHILD cohort, we found that children born to mothers who regularly consumed NNS-229 sweetened beverages had higher BMI and adiposity by three years of age. This association was attenuated 230 after adjusting for maternal BMI and other confounders, which cannot be fully disentangled in an 231 observational study. Thus, to establish causality and investigate biological mechanisms, we undertook 232 experiments in mice, finding that offspring exposed to NNS in utero had increased adiposity compared 233 to controls, consistent with our observation in the CHILD cohort. 234
235
Our results add to an emerging body evidence from rodent studies examining early-life NNS exposure. 236 Collison et al. (23) showed that exposing mice to aspartame in utero and throughout life (55 mg/kg/day, 237 1.4-fold ADI) resulted in increased body weight, visceral fat deposition, and fasting glucose levels, while 238 von Poser Toigo et al. (25) found that male rat offspring exposed to high levels of aspartame (343 239 mg/kg/day, 8.6-fold ADI) during gestation had increased weight gain. In contrast, Olivier-Van Stichelen 240 et al. found that maternal NNS throughout pregnancy and lactation either had no impact (for sucralose 241 combined with acesulfame-K at levels approximating the ADI) or reduced offspring body weight (for 242 higher doses of ~2-fold ADI) (24), although adiposity was not measured and the offspring were not 243 followed beyond weaning. Here, we separately assessed physiologically-relevant doses of aspartame and 244 sucralose consumption. We showed that exposures approximating the human ADI of these NNSs during 245 pregnancy and lactation increased body weight in male offspring, primarily due to an increase in their 246 adiposity. Interestingly, and similar to sex-specific findings by Collison et al. (23) , female offspring did 247 not experience these effects. These findings are also consistent with sex differences observed in the 248 CHILD infants at 1 year of age (14), although not replicated in our current analysis at 3 years of age. 249
Further research is needed to understand the potentially sex-specific effects of NNS during critical 250 periods of development. 251
252
We also uniquely evaluated the impact of maternal NNS intake on glucose and insulin tolerance in the 253 offspring. Previously, Collison et al. found that exposure to 55 mg/kg/day of aspartame throughout 254 gestation and postnatal life increased fasting blood glucose levels in both male and female offspring and 255 decreased insulin sensitivity in male offspring only (23). While we did not detect differences in fasting 256 blood glucose in NNS-exposed offspring, we did observe greater insulin resistance in the male offspring, 257
which was consistent with their obesity. Since insulin resistance typically precedes the development of 258 glucose intolerance and hyperglycemia, it is possible that these phenotypes could develop with advanced 259 age or the addition of a high calorie diet. 260 261 Finally, we used a cell culture model of adipocyte differentiation to further explore the mechanisms of 262 NNS-induced adiposity observed in the CHILD cohort and mouse offspring. Previously it was reported 263 that saccharin and aspartame affected adipocyte differentiation and lipid metabolism (27-29), but these 264 studies used extremely high millimolar dosages. Since we observed the greatest effects of sucralose on 265 male mouse offspring, we treated male 3T3-L1 pre-adipocyte cells with 200nM sucralose at different 266 stages of the differentiation process. We found that sucralose exposure very early in the differentiation 267 program had the greatest effect on increasing lipid accumulation within the cells. In addition, this 268 treatment increased the expression of several transcription factors that convert pre-adipocytes into 269 adipocytes and have key roles in the regulation of lipid and glucose metabolism by adipocytes (31). These 270 include PPAR-γ and C/EBP-α, as well their downstream target genes Adipoq, Fabp4 and Plin2. 271 Moreover, sucralose stimulated the expression of several genes involved in lipid metabolism, including 272
Fasn, Gpam, Lipe and Atgl. Importantly, we confirmed that these changes in gene expression were also 273 present in adipose tissues isolated from male offspring exposed to sucralose in utero. Together, these 274 findings suggest that sucralose can directly induce a pro-adipogenic gene expression program at doses 275 that approximate human consumption. 276
277
The major strength of this study is our translational approach. We used data from a large, longitudinal 278 national birth cohort that collected objective measures of body composition and accounted for many 279 possible confounders. We performed complementary mechanistic studies in mice and cultured 280 adipocytes, and assessed two different NNS at physiologically-relevant doses. Limitations of the CHILD 281 cohort study include the limited assessment of NNS in beverages, without details on the type of NNS, or 282 NNS in foods, which are an increasingly common source of NNS exposure. As in all observational 283 studies, residual confounding is also possible, although we accounted for key factors including maternal 284 BMI, diabetes and diet quality. To overcome these limitations, we used experimental models to address 285 causality and examine mechanisms. A limitation of our mouse study is that we did not separate the effects 286 of NNS during pregnancy and lactation. A limitation of our adipocyte differentiation study is that 287 although we used a dose that is relevant to human consumption, sucralose is not fully absorbed from the 288 gut (32); therefore, the dose we applied to our cell culture system might be higher than what is achieved 289 in vivo. However, our in vitro results were confirmed in mouse adipose tissue, demonstrating the 290 compatibility of these model systems. Overall, our findings from the CHILD cohort and the experimental 291 model systems are complementary and provide new insights into the biological impact of prenatal NNS 292 exposure. 293 294 Further research is needed to confirm and characterize the potentially sex-specific biological mechanisms 295 by which prenatal NNS exposure influences postnatal weight gain and adiposity. In addition to 296 stimulating adipocyte differentiation, NNS may alter the maternal microbiome (33, 34), which is 297 transmitted to the offspring during birth and postnatal interactions (35, 36) , and contributes to host 298 metabolism and weight gain (37) (38) (39) . Future studies should also assess other types and sources of NNS, 299 such as plant-derived NNS and NNS in foods. Finally, it will be important to study and model the 300 maternal conditions that motivate NNS use, notably obesity and gestational diabetes, to clearly establish 301 and disentangle their independent effects on offspring development. This research will be important for 302 establishing the long-term safety of prenatal NNS exposure, and informing recommendations for 303 pregnant women. 304
305
In summary, our translational research provides new evidence that exposure to NNS in utero stimulates 306 postnatal weight gain, insulin resistance, and adiposity. Associations observed in the CHILD cohort were 307 investigated in experimental model systems, revealing a previously unknown mechanism involving 308 altered expression of pro-adipogenic (e.g. Cebpa) and lipid metabolism genes (e.g. Gpam, Fasn). 309
Collectively, these results suggest that maternal NNS consumption is a modifiable obesogenic exposure 310 that may be contributing to the global obesity epidemic, and call for further research on the long-term 311 metabolic effects of NNS exposure in early life. 312 313
Materials and Methods 314
CHILD birth cohort 315
We accessed data from the CHILD cohort, a national population-based pregnancy cohort of 3455 families 316 across four sites in Canada, enrolled between 2008-12 (40) . For the current study, we included 2298 317 mother-infant dyads with complete data on maternal NNS consumption and child BMI at 3 years of age. 318
This study was approved by the Human Research Ethics Boards at the Hospital for Sick Children, 319
McMaster University and the Universities of Manitoba, Alberta, and British Columbia. 320
Maternal dietary assessment 321
Maternal sweetened beverage consumption during pregnancy was documented in the CHILD study using 322 a food frequency questionnaire (FFQ) (41, 42) as described previously (14). NNS beverages included 323 "diet soft drinks or pop" (1 serving = 12 oz or 1 can) and "artificial sweetener added to tea or coffee" (1 324 serving = 1 packet). Sugar-sweetened beverage (SSB) intake was similarly determined from consumption 325 of "regular soft drinks or pop" and "sugar or honey added to tea or coffee" (1 serving = 1 teaspoon or 1 326 packet). Beverage intakes were classified according to the number of servings per week as: never or <1 327 per month, ≤1 per week, 2 -6 per week, or ≥1 per day (43). Total energy intake (kcal/day) and the 328 Healthy Eating Index (HEI-2010 score) (44) were derived from FFQ data using food composition tables 329 from the University of Minnesota Nutrition Coding Center nutrient database (Nutrition Coordinating 330
Center, Minneapolis, MN). Sweetened beverage consumption was assessed in children at 3 years of age. 331
Since consumption was relatively infrequent, it was simply categorized as any vs. none. 332
Child body composition 333
At 3 years of age, height, weight, and subscapular skin folds were measured by trained CHILD study 334 staff following a standardized protocol. Age-and sex-specific z-scores were calculated against the 2006 335 World Health Organization reference. 336
Covariates and confounders 337
Child sex, birth weight, gestational age, and maternal age were collected from hospital records. Maternal 338 BMI was calculated from measured height and self-reported pre-pregnancy weight (14). Maternal 339 smoking during pregnancy and education (as an indicator of socioeconomic status) was determined via 340 questionnaire. Diabetes during pregnancy (gestational or otherwise) was determined from hospital 341 records and self-report. Breastfeeding duration was reported by a standardized questionnaire. Child 342 screen time was measured in hours per day as an indicator of physical inactivity. Fresh and frozen food 343 consumption were ascertained via questionnaire as a basic indicator of child diet quality. 344
Experimental mouse model 345
All procedures were approved by the Animal Welfare Committee of the University of Manitoba, which 346 adheres to the principles for biomedical research involving animals developed by the Canadian Council 347 on Animal Care and the Council for International Organizations of Medical Sciences. All mice were 348
given ad libitum access to chow diet and water. Food and water consumption was monitored throughout 349 the experiment. Male and female C57BL6J mice were obtained at 8 weeks of age from the University of 350 Manitoba colony and were mated. Following mating, chow-fed dams were randomly assigned to drinking 351 water (control), sucrose (45 g/L, ~7.2 g/kg body weight/day anticipating 4 mL water intake and 25 g 352 body weight), aspartame (0.2 g/L, ~32 mg/kg body weight/day) or sucralose (0.04 g/L, ~6.4 mg/kg body 353 weight/day) throughout pregnancy and lactation. In a preliminary dose-finding study, dams received low 354 (0.05g/L), medium (0.1g/L) and high (0.2g/L) levels of aspartame or alternatively low (0.01g/L), medium 355 (0.02g/L) and high levels (0.04g/L) of sucralose consumption (Table S6) . These NNS concentrations are 356 relevant to human consumption as they translated to doses near or below the acceptable daily intake 357 limits for humans (40 mg/kg for aspartame and 5 mg/kg for sucralose). . Dams were allowed to deliver 358 naturally and at birth and when necessary, litters were reduced to eight pups (i.e.-4 males and 4 females) 359 to avoid competition for food. Beginning at 3 weeks of age (the usual weaning age for mice), offspring 360 were fed regular chow and tap water. Food and water intake and body weight were measured weekly for 361 all offspring. At 12 weeks of age, offspring were anesthetized by intraperitoneal injection of a sodium 362 pentobarbital overdose and blood was collected by cardiac puncture. Tissues were dissected, rinsed in 363 PBS, weighed, and either fixed in 10% formalin or freeze clamped in liquid nitrogen and stored at -80 o C 364 for future analyses. For all analyses, data from cagemates were averaged and the litter was used as the 365 unit of analysis (i.e.-n=6 litters per group were generated). 366
Dual-Energy X-ray Absorptiometry (DEXA) 367
DEXA scans were performed on 11 week-old mouse offspring at CHRIM (Children's Hospital Research 368 Institute of Manitoba) facilities. A technician blinded to the offspring experimental groups took all the 369 images once mice were anesthetized using isoflurane gas and immobilized. 370
Adipose tissue histology and morphometry 371
Histopathological preparations and hematoxylin/eosin (HE) staining were performed by the University 372 of Manitoba Core Platform for Histology according to standard procedures. For the analysis of adipocyte 373 size and number, the internal diameters of 80 consecutive adipocytes from 2 randomly selected fields on 374 each HE stained slide were measured under light microscopy using a digital micrometer under 20x 375 magnification and averaged. 376
Evaluation of glucose and insulin tolerance 377
A glucose tolerance test (GTT) and insulin tolerance test (ITT) were performed on 11 week-old offspring, 378 as described previously (45). For a GTT, mice were fasted overnight and injected intraperitoneally with 379 a 50% glucose solution (2g/kg). Blood glucose concentrations were determined using an ACCU-CHEK 380 advantage glucose meter (Roche Diagnostics) using blood collected from the tail and after a glucose 381 injection (at 15, 30, 45, 60, 90 and 120 min) . For the insulin tolerance test, human recombinant insulin 382 was used to prepare an insulin-saline solution that was injected intraperitoneally (1mU/kg) after a 4h fast 383 and blood glucose from the tail was measured at baseline and after insulin injection (at 30, 60, 90 and 384 120 min). 385
Cell culture 386 3T3-L1 pre-adipocyte cells were differentiated as described previously (46). Two days post confluency 387 (Day 0), the cells were stimulated with 1 μM dexamethasone, 1 μg/ml insulin and 0.5mM methylisobutyl-388 xanthine in 10% Fetal Bovine Serum(FBS)/Dulbecco's Modified Eagle's Medium media (Sigma). Cells 389 were fed with fresh media every two days, with insulin and FBS on Day 2 and FBS alone from Day 4 390 until Day 8. Throughout adipocyte differentiation, 200nM sucralose was added at different stages of 391 cellular development (Fig. 3A) until day 8. At Day 8, the cells reached full differentiation and samples 392 were collected for analysis. After fixing cells with 10% formaldehyde for 2h at room temperature, washed 393 with 60% isopropanol, lipid accumulation was evaluated by oil red O staining for 1h at room temperature 394 and washed twice with distilled water. An EVOS digital inverted microscope (AMG) was used to capture 395 microscopic pictures of the plates. Approximately 12 pictures were taken for every 100mm plate. 7 396 pictures were taken around the outside of the plate and 5 were taken around the center of the plate. 397
Analysis of mRNA expression 398
RNA was isolated from tissues and cells using a QIAshredder column and further purified using the 399 RNeasy kit (Qiagen, Valencia CA). For qPCR analysis, cDNA was synthesized using the Protoscript kit 400 (NEB, Ipswich, MA, USA). The QuantiTect SYBR Green PCR kit (Qiagen, Valencia CA, USA) was 401 used to monitor amplification of cDNA on an CFX96 real-time PCR detection machine 402 Hercules, CA). Expression of genes was assessed in duplicate using 2-CT and data was normalized 403 by the geometric averaging of multiple control genes (47), including eukaryotic initiation factor 2a 404 (eIF2a) and cyclophilin A as the reference genes that were constant across all groups of offspring. Primer 405 sequences were validated and are reported in Table S7 . We are grateful to all the families who took part in the CHILD study, and the whole CHILD team, which 568 includes interviewers, nurses, computer and laboratory technicians, clerical workers, research scientists, 569 volunteers, managers, and receptionists. We also acknowledge the excellent technical work of Mario 570 Supplemental Table S1 . Maternal and child characteristics according to maternal consumption of NNSsweetened beverages during pregnancy in the CHILD birth cohort. Values are mean ± standard deviation for continuous variables, or percentages for binary variables. *Test for difference across NNS consumption categories, by ANOVA for continuous variables or chi-squared for binary variables. HEI, healthy eating index 2010 (maximum 100); NNS, non-nutritive sweeteners. Supplemental Table S3 . Maternal sweetened beverage consumption during pregnancy and child subscapular skinfold z-score at 3 years of age in the CHILD cohort NNS, non-nutritive sweetener; SS, sugar-sweetened. BMI, body mass index; β, beta estimate; CI, confidence interval; SD, standard deviation. *Pregnancy/ early life covariates include maternal total energy intake and Healthy Eating Index score, maternal postsecondary education, maternal smoking and diabetes in pregnancy, breastfeeding duration, and child sex. **3y covariates include child screen time, fresh and frozen food intake, and soda consumption. All models are mutually adjusted for both beverage types.
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